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Abstract. 
 
In 
 
Saccharomyces cerevisiae
 
, amino acid per-
meases are divided into two classes. One class, repre-
sented by the general amino acid permease GAP1, con-
tains permeases regulated in response to the nitrogen 
source. The other class, including the high afﬁnity tryp-
tophan permease, TAT2, consists of the so-called con-
stitutive permeases. We show that TAT2 is regulated at 
the level of protein stability. In exponentially growing 
cells, TAT2 is in the plasma membrane and also accu-
mulates in internal compartments of the secretory path-
way. Upon nutrient deprivation or rapamycin treat-
ment, TAT2 is transported to and degraded in the 
vacuole. The ubiquitination machinery and lysine resi-
 
dues within the NH
 
2
 
-terminal 31 amino acids of TAT2 
mediate ubiquitination and degradation of the per-
mease. Starvation-induced degradation of internal 
TAT2 is blocked in 
 
sec18
 
, 
 
sec23
 
, 
 
pep12
 
, and 
 
vps27
 
 mu-
tants, but not in 
 
sec4
 
, 
 
end4
 
,
 
 
 
and
 
 apg1 
 
mutants, suggest-
ing that, upon nutrient limitation, internal TAT2 is di-
verted from the late secretory pathway to the vacuolar 
pathway. Furthermore, our results suggest that TAT2 
stability and sorting are controlled by the TOR signal-
ing pathway, and regulated inversely to that of GAP1.
Key words: GAP1 • TOR • rapamycin • ubiquitin • 
endocytosis
 
A
 
MINO
 
 acid permeases and homologues in yeast form a
family of 23 members with demonstrated or sus-
pected transport activity, and an additional mem-
ber with a presumed regulatory function (Nelissen et al.,
 
1997; Didion et al., 1998)
 
.
 
 Based on their function and reg-
ulation, the amino acid permeases are divided into two
classes (Sophianopoulou and Diallinas, 1995). Permeases
of one class, including the general amino acid permease,
GAP1,
 
1
 
 and the proline permease, PUT4, are regulated in
response to the available nitrogen source (Jauniaux et al.,
1987; Jauniaux and Grenson, 1990; Vandenbol et al.,
1990). In the presence of a good nitrogen source, such as
ammonium or glutamine, the uptake activity by these per-
meases is low, whereas in media containing a poor nitro-
gen source, such as proline or urea, transport activity is
strongly induced. Both permeases transport amino acids
that can be used as a nitrogen source. The nitrogen-depen-
dent regulation of GAP1 is complex, occurring at the lev-
 
els of 
 
GAP1
 
 transcription and GAP1 sorting and degrada-
tion (Stanbrough and Magasanik, 1995; Roberg et al.,
1997b; Springael and Andre, 1998). The second class of
amino acid permeases consists of mainly high affinity
transporters that are specific for single amino acids or a
small set of structurally related amino acids. These per-
meases, including the histidine permease, HIP1 (Tanaka
and Fink, 1985), and the tryptophan permease, TAT2
(Schmidt et al., 1994), import amino acids primarily for use
in protein synthesis. They are thought not to be regulated
and are thus often referred to as the constitutive per-
meases.
 
Newly made amino acid permeases, despite lacking
an NH
 
2
 
-terminal signal sequence, are inserted into the
membrane of the endoplasmic reticulum (Ljungdahl et
 
al., 1992). Assisted by the ER-resident protein SHR3,
the permeases are then packaged into coatomer protein
(COP)-II vesicles (Kuehn et al., 1996), and routed through
the secretory pathway to the plasma membrane, where
they actively import their amino acid substrates. For
GAP1, it has recently been shown that transport from the
Golgi to the plasma membrane is not a default process.
Depending on the nitrogen source, GAP1 is delivered
from the Golgi to either the vacuole or the plasma mem-
brane. In the presence of a good nitrogen source, GAP1 is
routed to the vacuole and degraded, whereas, in the pres-
ence of a poor nitrogen source, GAP1 is targeted to the
plasma membrane (Roberg et al., 1997a,b).
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The GAP1 permease, like many other integral plasma
membrane proteins, is removed from the plasma mem-
brane via ubiquitin-triggered internalization (Hicke and
Riezman, 1996; Hicke, 1997; Springael and Andre, 1998).
The NPI1/RSP5 ubiquitin-protein ligase is required for
GAP1 ubiquitination. NPI1/RSP5 was originally identified
as the nitrogen permease inactivator for GAP1 (Hein et al.,
1995; Jauniaux et al., 1987). After internalization, GAP1 is
transported to the vacuole for degradation.
The immunosuppressant rapamycin induces a starvation
state in yeast cells, stationary phase or G0, by binding and
inhibiting target of rapamycin (TOR) 1 and TOR2 (Heit-
man et al., 1991; Stan et al., 1994; Zheng et al., 1995; Barbet
et al., 1996). The TOR proteins, two highly homologous
phosphatidylinositol kinase-related kinases (Kunz et al.,
1993; Helliwell et al., 1994), normally control cell growth by
signaling activation of translation initiation and early G1
progression in response to nutrients (Barbet et al., 1996; Di
Como and Arndt, 1996; Berset et al., 1998). TOR2 also ac-
tivates a Rho-type GTPase switch and thereby controls the
cell cycle–dependent organization of the actin cytoskeleton
(Schmidt et al., 1996, 1997; Bickle et al., 1998). However,
this TOR2 unique function is not rapamycin sensitive
(Zheng et al., 1995; Schmidt et al., 1996).
Here we show that the constitutive permease TAT2 is
indeed regulated. Inversely to GAP1, TAT2 is targeted to
the vacuole and degraded upon nutrient deprivation. Sur-
prisingly, an internal pool of TAT2 appears to be routed
directly to the vacuole independently of the plasma mem-
brane. Furthermore, the regulated sorting of TAT2 is con-
trolled by the TOR proteins.
 
Materials and Methods
 
Strains, Plasmids, and Media
 
S
 
.
 
 cerevisiae
 
 strains used in this work are listed in Table I. Plasmids used in
this work are listed in Table II. Rich medium (YPD) was prepared as de-
scribed (Sherman, 1991). Synthetic complete medium (SC) lacking the ap-
propriate nutrients for plasmid maintenance was as described (Sherman,
1991) with the following modifications. Tryptophan was added to 40 
 
m
 
g/ml,
leucine to 100 
 
m
 
g/ml, and glutamic acid, aspartic acid, and serine were
omitted. Ammonium and proline media, or media without ammonium or
proline as a nitrogen source, were prepared using yeast nitrogen base
without ammonium sulfate and amino acids supplemented with 2% glu-
cose, 40 
 
m
 
g/ml tryptophan, 20 
 
m
 
g/ml histidine, 100 
 
m
 
g/ml leucine, and ei-
ther 10 mM ammonium sulfate or 1 mg/ml proline, or no ammonium or
proline. Rapamycin (gift of Sandoz Pharmaceutical) was dissolved at 1
mg/ml in drug vehicle (90% ethanol and 10% Tween-20) and added to liq-
uid media to a final concentration of 200 ng/ml.
 
Genetic Techniques
 
Yeast transformation was performed by the lithium acetate procedure
(Ito et al., 1983). 
 
Escherichia coli
 
 strain DH5
 
a
 
 was used for propagation
and isolation of plasmids as described (Ausubel et al., 1998).
 
DNA Manipulations
 
Restriction enzyme digests and ligations were done by standard methods.
Enzymes and buffers were obtained commercially (Boehringer Mann-
heim). DNA was sequenced by the dideoxy-chain termination method
with the T7 sequencing system (Pharmacia).
 
Construction of HA-tagged and Mutant TAT2
 
HA-TAT2 
 
(in pAS55, pAS64, or pTB287) encodes an NH
 
2
 
-terminally
HA-tagged, fully functional TAT2 protein under control of its own pro-
 
moter. 
 
HA-TAT2
 
 was constructed by ligating a 0.65-kb PstI-XbaI
 
 
 
PCR
product, containing the 
 
TAT2
 
 promoter, 5
 
9
 
 untranslated region, initiation
codon, and double HA tag, to a 2.3-kb XbaI-EcoRI PCR product contain-
ing the 
 
TAT2
 
 open reading frame and 3
 
9
 
 noncoding region. The PstI and
EcoRI sites were natural sites flanking the 
 
TAT2
 
 gene. The PCR primers
used to generate the 0.65-kb fragment were 5
 
9
 
-CG
 
TCTAGA
 
TGCATA-
GTCCGGGACGTCATAGGGATAGCCCGCATAGTCAGGAACA-
TCGTATGGGTA
 
CAT
 
ATGAGAGTGTGTTGCGTAATTTG-3
 
9
 
 (XbaI
site in italics, antisense 2
 
3
 
HA open reading frame underlined and anti-
sense initiation codon in bold) and the 1233 primer (New England
Biolabs). The primers used to generate the 2.3-kb fragment were 5
 
9
 
-
CG
 
TCTAGA
 
ACCGAAGACTTTATTTCTTCTGTC-3
 
9
 
 (XbaI site in
italics) and the 
 
2
 
20 primer (New England Biolabs). To create deletion
variants, the following primers were used in combination with the 
 
2
 
20
primer (New England Biolabs) to generate alternative 2.3-kb fragments:
5
 
9
 
-GG
 
TCTAGA
 
ATGCGTTCAAATGAGGAGCTG-3
 
9
 
 (
 
TAT2
 
D
 
10
 
), 5
 
9
 
-
GG
 
TCTAGA
 
ATGGAGCGAAAATCTAACTTTGG-3
 
9
 
 (
 
TAT2
 
D
 
17
 
),
5
 
9
 
-CG
 
TCTAGA
 
ATGTCTAACTTTGGATTTGTAG-3
 
9
 
 (
 
TAT2
 
D
 
20
 
), 5
 
9
 
-
CG
 
TCTAGA
 
TCCAAGCAATTAACATCATC-3
 
9
 
 (
 
TAT2
 
D
 
29
 
), 5
 
9
 
-CG
 
T-
CTAGA
 
TCCAGGCAATTAACATCATC-3
 
9
 
 (
 
TAT2
 
D
 
29
 
K31R
 
) and 5
 
9
 
-
GG
 
TCTAGA
 
CAATTAATATCATCCTCATC-3
 
9
 
 (
 
TAT2
 
D
 
31
 
). An inter-
nal deletion (
 
TAT2
 
D
 
17-31
 
) was constructed in a two-step PCR with the
complementary primers 5
 
9
 
-TCAAATGAGGAGCTGCAATTAACAT-
CATCC-3
 
9
 
 and 5
 
9
 
-GGATGATGTTAATTGCAGCTCCTCATTTGA-
3
 
9
 
, each in combination with a flanking primer and pTB287 as the tem-
plate. 
 
TAT2
 
5K
 
.
 
R
 
 was reconstituted from two PCR fragments generated
with primers 5
 
9
 
-GC
 
GAGCTC
 
CTCATTTGAACGCCTGACAGAAGA-
3
 
9
 
 (antisense) and 5
 
9
 
-GAG
 
GAGCTC
 
AGGGAGCGAAGATCTAA-
CTTTGGATTTGTAGAATACAGATCCAGGCAATTAACATCAT-
CCTCATC-3
 
9
 
 (sense), each in combination with a flanking primer and
pTB287 as the template. A silent nucleotide substitution that created a
SacI site (italics) is indicated in bold, and point mutations that changed
lysine codons to arginine codons are underlined. Vent DNA Polymerase
(New England Biolabs) or 
 
Taq
 
 polymerase (Boehringer Mannheim) was
used in PCR. Mutations, deletions, and introduction of the HA tag-encod-
ing sequence in 
 
TAT2
 
 were verified by sequencing.
 
Amino Acid Import Studies
 
The import rates of radiolabeled amino acids (
 
L
 
-[5-
 
3
 
H]-tryptophan (33 Ci/
mmol), 
 
L
 
-[4,5-
 
3
 
H]-leucine (58 Ci/mmol), and 
 
L
 
-[2,5-
 
3
 
H]-histidine (42 Ci/
mmol; Amersham) were measured as described (Heitman et al., 1993),
with the following modifications. Wild-type (JK9-3d) cells were grown to
early logarithmic phase in YPD medium at 30
 
8
 
C, and the culture was split
into six equal aliquots. Individual aliquots were incubated at 30
 
8
 
C in the
presence of rapamycin for either 0, 15, 30, 45, 60, or 90 min. Uptake of la-
beled amino acids (% import/OD over time) was determined for cells of
each aliquot. For the graph in Fig. 1 A the 10-min timepoint of each curve
was plotted over the rapamycin preincubation time of the given aliquot.
 
Table I. Strains
 
Strain Genotype
 
JK9-3D
 
MAT
 
a
 
 
 
his4 leu2 ura3 trp1 rme1HMLa
 
MH684 JK9-3d
 
a
 
 
 
pep4::URA3
 
23344c
 
MAT
 
a
 
 ura3
27038a
 
MAT
 
a
 
 
 
npi1 ura3
 
27002d
 
MAT
 
a
 
 
 
doa4/npi2 ura3
 
RH1552
 
MAT
 
a
 
 
 
sec4-1 his4 lys2 ura3
 
RSY255
 
MAT
 
a
 
 
 
leu2 ura3
 
RSY271
 
MAT
 
a
 
 
 
sec18-1 his4 ura3
 
RSY281
 
MAT
 
a
 
 
 
sec23-1 his4 ura3
 
MT16-9B
 
MAT
 
a
 
 
 
apg1-1 leu2 ura3
 
RH1602
 
MAT
 
a
 
 
 
his4 leu2 ura3 bar1
 
RH1597
 
MAT
 
a
 
 
 
end4-1 his4 leu2 ura3 bar1
 
RH2378
 
MAT
 
a
 
 
 
VPS27 his4 leu2 ura3
 
RH2379 MATa vps27ts his4 leu2 ura3
SEY6210 MATa PEP12 his3 leu2 ura3 trp1 lys2 suc2
CBY9/5C MATa pep12ts ade2 his3 leu2 ura3 trp1 lys2 suc2Beck et al. TOR Controls Amino Acid Permeases 1229
Western Analysis
To prepare whole cell extracts for SDS-PAGE and Western analysis, cells
were grown in SC medium to early logarithmic phase, resuspended in ice-
cold extraction buffer (120 mM NaCl, 50 mM Tris-HCl, pH 7.5, 2 mM
EDTA, 1 mM PMSF, and 1% NP-40) and lysed with glass beads in a Mini-
Beadbeater (Biospec Products). Unbroken cells and debris were removed
by a 500-g spin, and protein concentrations were determined using the
BioRad microassay. Samples were denatured at 378C for 10 min. A total
of 50 mg protein was loaded per lane for standard SDS-PAGE (10% acryl-
amide) and Western analysis (Ausubel et al., 1998). For detection of
tagged proteins, a rat anti-HA antibody (clone 3F10; Boehringer Mann-
heim) and mouse anti-myc antibody (9E10; kindly provided by H.-P.
Hauri, Biozentrum, University of Basel, Basel, Switzerland) were used.
For signal detection, the Amersham ECL kit was used; stripping of blots
and reprobing were performed as recommended by the manufacturer.
Indirect Immunofluorescence
Untreated logarithmically growing cells or cells treated with rapamycin
for 60 min were fixed for 2 h in the growth medium supplemented with
formaldehyde (3.7% final) and potassium phosphate buffer (100 mM fi-
nal, pH 6.5). Cells were washed and resuspended in sorbitol buffer (1.2 M
sorbitol and 100 mM potassium phosphate, pH 6.5). Cell walls were di-
gested for 30 min at 378C in sorbitol buffer supplemented with b-mercap-
toethanol (20 mM final) and recombinant lyticase (5 mg/ml) or zymolyase
20T (12.5 mg/ml; Seigagaku Corporation), yielding identical results.
Spheroblasts were fixed on poly-L-lysine–coated glass slides and perme-
abilized with PBT (53 mM Na2HPO4, 13 mM NaH2PO4, 75 mM NaCl, 1%
BSA, and 0.1% Triton X-100). Immunofluorescence directed against the
HA-epitope was performed by application of a high affinity monoclonal
anti-HA antibody (clone 16B12; Babco) at a dilution of 1:1,000 in PBT for
2 h, and subsequently of a Cy3-conjugated rabbit anti–mouse IgG (Molec-
ular Probes), diluted 1:1,000 in PBT, for 60 min. DNA was stained with
49,6-diamidino-2-phenylindole (DAPI; Sigma) at a concentration of 1 mg/ml.
Cells were visualized with a Zeiss Axiophot microscope (1003 objective)
and a video imaging system (MWG Biotech).
Cell Labeling and Immunoprecipitation
Logarithmically growing wild-type cells (JK9-3d) expressing HA-TAT2
were diluted in 400 ml SC medium (starting OD600 5 0.1) containing 2
mCi of L-[35S]methionine (Easytag protein labeling system; NEN). After
4 h (OD600 5 0.3), a 1,000-fold excess of cold methionine was added. The
culture was split, and rapamycin or empty drug vehicle was added. Tem-
perature-sensitive sec4 cells (RH1552) grown at 248C to early logarithmic
phase and expressing HA-TAT2 or HA-TAT25K.R were chilled on ice,
harvested by centrifugation, and immediately resuspended at an OD600 5
5 in 12 ml of SC medium containing 2 mCi of L-[35S]methionine instead of
cold methionine. Cells were incubated for 3 min at 248C, then shifted to
378C for an additional 5 min. The cultures were chilled on ice, harvested,
and resuspended at an OD600 5 0.5 in prewarmed (378C) SC medium con-
taining cold methionine and rapamycin (200 ng/ml). Culture aliquots
equal to 15 OD600 of cells were removed after 0, 30, 60, and 90 min, and
kept on ice for 10 min in the presence of 10 mM NaN3 and 10 mM NaF.
Cells were harvested and cell extracts prepared as described above. Ex-
tracts were precleared for 30 min with Sepharose CL-4B, and incubated
for 2 h at 48C with protein G immobilized on Sepharose CL-4B (Sigma)
and monoclonal anti-HA antibodies (12CA5 or 16B12; Babco), in a vol-
ume of 1 ml. The beads were collected and washed extensively with ex-
traction buffer. Bound protein was solubilized by incubating in SDS sam-
ple buffer (Ausubel et al., 1998) for 10 min at 378C. Gels were scanned
and signals quantified using a PhosphorImager (Molecular Dynamics) and
ImageQuant software. Ubiquitinated TAT2 was visualized in Western
blots by use of monoclonal anti-myc antibody (clone 9E10). For this pur-
pose, myc-tagged ubiquitin was expressed as described (Ellison and Hoch-
strasser, 1991), in wild-type cells (JK9-3d) also expressing HA-TAT2,
HA-TAT25K.R, or untagged TAT2. The permease was immunoprecipi-
tated from extracts of these cells (from a total of 1 mg of protein) as de-
scribed above.
Results
Starvation Induces Downregulation of TAT2
We observed that amino acid prototrophic yeast strains
are less sensitive to rapamycin than auxotrophic strains
(Beck, T., A. Schmidt, and M.N. Hall, unpublished obser-
vation). Because auxotrophic strains rely on the uptake of
externally added amino acids for growth, this suggested
that rapamycin inhibits amino acid import. We measured
the import of radiolabeled tryptophan in cells treated with
rapamycin for various times, and found a significant and
early decrease in tryptophan uptake (Fig. 1 A). The time-
dependent decrease in tryptophan import was followed,
with a short time lag, by a downregulation in the level of
TAT2 protein (Fig. 1 A). Tryptophan import and TAT2
protein dropped to almost undetectable levels after 60 min
of rapamycin treatment.
As rapamycin causes starvation in yeast cells, the rapa-
mycin-induced downregulation of TAT2 appeared to be a
novel starvation response. To confirm that the downregu-
lation of TAT2 is indeed a starvation response, we exam-
ined if nutrient deprivation causes a similar downregula-
Table II. Plasmids
Plasmid Description
pTAT2 pAS8; 3.7-kb EcoRI fragment containing TAT2 in pSEY18 (2m URA3)
pHA-TAT2 pAS55; TAT2 promoter-HA-TAT2 in YEplac195 (2m URA3)
pAS64; TAT2 promoter-HA-TAT2 in YEplac181 (2m LEU2)
pTB287; TAT2 promoter-HA-TAT2 in YCplac33 (CEN URA3)
pHA-TAT2D29 pTB288; pAS55 containing a deletion of codons 2 through 29 of TAT2
pHA-TAT2D17-31 pTB294; pAS55 containing a deletion of codons 17 through 31 of TAT2
pHA-TAT2D10 pTB306; pAS55 containing a deletion of codons 2 through 10 of TAT2
pHA-TAT2D17 pTB307; pAS55 containing a deletion of codons 2 through 17 of TAT2
pHA-TAT2D20 pTB313; pAS55 containing a deletion of codons 2 through 20 of TAT2
pHA-TAT2D29 pTB348; pAS55 containing a deletion of codons 2 through 29 of TAT2
pHA-TAT2D29K31R pTB373; pTB348 with a nucleotide substitution changing lysine codon 31 of TAT2 to arginine
pHA-TAT2D31 pTB359; pAS55 containing a deletion of codons 2 through 31 of TAT2
pHA-TAT2D5K.R pTB355; pAS55 with nucleotide substitutions changing lysine codons 10, 17, 20, 29, and 31 of TAT2 to arginine codons
pPL230 pRS316::SHR3-HA (Ljungdahl et al., 1992)
pPL257 pRS316::GAP1-HA (Ljungdahl et al., 1992)
pPL321 pRS316::HIP1-myc (Kuehn et al., 1996)
YEp105 encodes myc-tagged ubiquitin under control of the copper-inducible CUP1 promoter (Ellison and Hochstrasser, 1991)The Journal of Cell Biology, Volume 146, 1999 1230
tion. Wild-type cells grown to early logarithmic phase in
medium containing glucose, ammonium, and required
amino acids (SC medium) were harvested by filtration and
resuspended in normal SC medium and in nutrient-modi-
fied SC medium. TAT2 protein levels were then examined
after 60 min of incubation in the new media. First, the me-
dium was modified by increasing, decreasing, or removing
tryptophan. Whereas increasing (203; 800 mg/ml) and de-
creasing (0.13; 4 mg/ml) the tryptophan concentration had
little or no effect, tryptophan starvation resulted in an al-
most complete loss of TAT2 protein (Fig. 1 B, upper
panel). Second, cells were shifted to medium modified in
the nitrogen source, i.e., medium containing a reduced
amount of ammonium (0.13; 1 mM), no ammonium, or
proline instead of ammonium. As shown in Fig. 1 B (mid-
dle panel), nitrogen limitation correlated with a decrease
in the level of TAT2 protein, up to a complete loss of the
permease in ammonium-free and proline media. In con-
trast to TAT2, GAP1 is activated upon shift from ammo-
nium to the poor nitrogen source proline, and inactivated
(degraded) upon shift from proline to ammonium (Ma-
gasanik, 1992; Springael and Andre, 1998), suggesting that
TAT2 and GAP1 are inversely regulated in response to
the nitrogen source. Third, cells were shifted to media with
reduced (0.13; 0.2%) or no glucose. The levels of TAT2
protein again correlated with nutrient availability, drop-
ping to undetectable levels in the absence of glucose (Fig.
1 B, lower panel). Thus, the downregulation of TAT2 pro-
tein is a novel starvation response, caused by either rapa-
mycin treatment or amino acid, nitrogen or carbon depri-
vation.
To determine whether the nutrient regulation observed
for TAT2 also occurs for other high affinity constitutive
permeases, we measured histidine import in rapamycin-
treated cells. The effect of rapamycin on histidine uptake
was similar to that observed for tryptophan uptake (not
shown). We also examined the abundance of myc-tagged
histidine permease HIP1 (Tanaka and Fink, 1985; Kuehn
et al., 1996) in rapamycin-treated cells. Like TAT2, HIP1
almost completely disappeared within 60 min of rapamy-
cin treatment (Fig. 1 C). Thus, starvation-induced down-
regulation is not unique to TAT2, but also applies to an-
other, and possibly to all, so-called constitutive amino acid
permeases. The starvation program in yeast may involve a
global downregulation of high specificity permeases.
In contrast to TAT2 and HIP1, rapamycin treatment
caused a significant increase in GAP1 protein, even in
the presence of nutrients (Fig. 1 C). The abundance of
SHR3, an ER-resident amino acid permease chaperone
(Ljungdahl et al., 1992), was not significantly affected by
rapamycin treatment (Fig. 1 C). Thus, the rapamycin-sen-
sitive TOR proteins appear to regulate inversely the high
specificity permeases, such as TAT2 and HIP1, and the
broad specificity permease GAP1, in response to nutrient
availability.
Starvation Induces Turnover of TAT2
Rapamycin also causes a downregulation in translation
initiation (Barbet et al., 1996). Because the downregula-
tion of translation is earlier than the observed downregu-
lation of TAT2, the decrease in TAT2 levels could reflect
a loss of de novo protein synthesis in combination with a
normally short half-life of the permease. We performed a
pulse–chase experiment to determine whether the loss of
TAT2 resulted from increased turnover or solely from re-
duced synthesis of the protein. Cells expressing HA-
tagged TAT2 were grown to early logarithmic phase in the
presence of radiolabeled methionine, and chased with an
excess of cold methionine in the presence or absence of ra-
pamycin. Culture aliquots were taken at 15-min intervals
and processed for immunoprecipitation of the permease.
As shown in Fig. 2, the half-life of TAT2 in the rapamycin-
treated cells was z30 min, whereas in the rapamycin-
untreated cells the half-life was .90 min. Thus, the TAT2
protein is significantly more stable in exponentially grow-
Figure 1. Starvation induces
downregulation of TAT2.
(A) Wild-type cells (JK9-3d)
treated with rapamycin for
different times were assayed
for tryptophan uptake (open
circles), as described in Ma-
terials and Methods. Wild-
type cells expressing HA-
TAT2 (JK9-3d/pAS55) and
treated with rapamycin for
different times were assayed
for the level of HA-TAT2
protein (TAT2, closed cir-
cles), by Western analysis as
described in Materials and
Methods. (B) Wild-type cells
expressing HA-TAT2 (JK9-
3d/pAS55) were grown in SC medium and shifted to SC medium modified in the concentration of tryptophan, ammonium (NH4
1), pro-
line or glucose, as described in the text. After 60 min of incubation in the modified media, protein extracts were prepared and analyzed
for HA-TAT2 by Western analysis. (C) Wild-type cells expressing HA-TAT2 (JK9-3d/pAS55), HIP1-myc (JK9-3d/pPL321), GAP1-
HA (JK9-3d/pPL257), or SHR3-HA (JK9-3d/pPL230) were grown in SC medium to early logarithmic phase. Rapamycin (1) or empty
drug vehicle (2) was added. After 60 min, cells were harvested and processed for Western analysis.Beck et al. TOR Controls Amino Acid Permeases 1231
ing cells than in starved cells, indicating that starvation in-
duces degradation of TAT2.
Turnover of TAT2 Requires Ubiquitination, 
Endocytosis, and Vacuolar Proteases
Degradation of TAT2 is likely to occur in a manner similar
to that of other permeases such as FUR4, GAP1, MAL61,
and GAL2. Upon NPI1/RSP5-dependent ubiquitination,
these proteins are internalized, transported to the vacuole,
and degraded by vacuolar hydrolases (Galan et al., 1996;
Hicke, 1997; Horak and Wolf, 1997; Lucero and Lagunas,
1997; Springael and Andre, 1998). To investigate the re-
quirements of TAT2 degradation, we analyzed the steady
state levels of HA-TAT2 in mutant and wild-type cells
treated with rapamycin or drug vehicle alone (Fig. 3 A). In
wild-type cells, TAT2 was almost completely degraded
within 60 min after addition of rapamycin, as described
above. In an npi1/rsp5 mutant, defective in the ubiquitin-
protein ligase NPI1/RSP5 (Springael and Andre, 1998),
the amount of TAT2 protein was significantly increased in
logarithmically growing cells, as compared with a wild-
type strain (NPI1), and the permease was still present
in rapamycin-treated cells. To confirm the involvement
of ubiquitin in the rapamycin-induced degradation of
TAT2, we examined another ubiquitination-deficient mu-
tant. The doa4/npi2 mutant, defective in a ubiquitin hydro-
lase (Jauniaux et al., 1987; Papa and Hochstrasser, 1993),
has a ubiqitination deficiency (Galan and Haguenauer-
Tsapis, 1997; Lucero and Lagunas, 1997), possibly due to a
defect in replenishing the pool of free ubiquitin (Galan
and Haguenauer-Tsapis, 1997; Singer et al., 1996). Like in
npi1/rsp5 cells, TAT2 was resistant to rapamycin-induced
degradation in the doa4/npi2 mutant. In an end4 mutant
(Raths et al., 1993), defective for endocytosis of several
plasma membrane proteins, TAT2 was weakly (z10%) re-
sistant to rapamycin-induced degradation. In a pep4 mu-
tant lacking vacuolar proteases, TAT2 was completely re-
sistant to rapamycin-induced degradation.
To further examine the requirements of TAT2 degrada-
tion, we analyzed the cellular distribution of TAT2 in the
above mutants and wild-type cells treated or untreated
with rapamycin (Fig. 4). Visualization of HA-TAT2 in ra-
pamycin-untreated wild-type cells by immunofluorescence
revealed a strong ER signal, a punctate signal reminiscent
of Golgi-localized proteins, and only weak plasma mem-
brane staining. This localization of TAT2 differs from that
of the uracil permease FUR4, which is found mainly in the
Figure 2. Starvation induces
turnover of TAT2. Logarith-
mically growing wild-type
cells expressing HA-TAT2
(JK9-3d/pAS55) were la-
beled with 35S-methionine. A
chase was performed by add-
ing an excess of cold me-
thionine, either alone or in
combination with rapamycin
(200 ng/ml). Aliquots of the
untreated and rapamycin-
treated cultures were re-
moved at the indicated times
of chase, and cell extracts
were prepared. HA-TAT2 was immunoprecipitated from these
extracts, eluted from the washed protein G–Sepharose beads at
378C, subjected to SDS-PAGE, and visualized by fluorography
(see Materials and Methods). Bars represent the average value
from two independent experiments.
Figure 3. Turnover of TAT2 requires ubiquitination, endocyto-
sis, and vacuolar proteases. (A) Parental wild-type strains (NPI1,
23344c; DOA4, 23344c; PEP4, JK9-3d) and npi1 (27038a), doa4
(27002d), and pep4 (MH684) mutants expressing HA-TAT2
(from pAS55 or, in the case of PEP4 and pep4, from pAS64),
were grown in SC medium at 308C to early logarithmic phase.
Rapamycin (rap) or empty drug vehicle was added. The parental
wild-type END4 strain (RH1602) and the conditional end4 mu-
tant (RH1597) were grown at 248C and shifted to 378C for 5 min
before the addition of rapamycin or empty drug vehicle. After 60
min in the presence of rapamycin, cells were harvested and pro-
cessed for Western analysis of HA-TAT2 (TAT2). (B) Wild-type
cells (JK9-3d) expressing either HA-TAT2 (pAS55), untagged
TAT2 (pAS8), or HA-TAT25K.R (pTB355), and containing a
plasmid for copper-inducible expression of myc-tagged ubiquitin
(YEp105) were grown in SC medium. Expression of myc-ub was
not induced (2) or induced (1) with copper sulfate (100 mM) for
3 h. Before harvesting, cells were treated for 15 min with rapamy-
cin (200 ng/ml). Cells were collected and processed for immuno-
precipitation with anti-HA (from 1 mg of total protein, see Mate-
rials and Methods). Immunoprecipitated protein was subjected
to Western analysis. The blot was probed with anti-HA antibody
(a-HA), stripped and reprobed with anti-myc antibody (a-myc).
The asterisk denotes a nonspecific band.The Journal of Cell Biology, Volume 146, 1999 1232
plasma membrane (Volland et al., 1992), but is similar to
that of GAP1 which can be found mainly in the ER and
Golgi (Roberg et al., 1997b). Furthermore, the distribu-
tion of TAT2 was the same, although the signal differed in
intensity, when HA-TAT2 was expressed from a single
copy plasmid (pTB287) or a multicopy plasmid (pAS55 or
pAS64) (data not shown). In rapamycin-treated wild-type
cells, the TAT2 signal became very faint, as expected, due
to degradation of the TAT2 protein, but did not change
significantly in pattern (data not shown). In rapamycin-
treated npi1/rsp5 cells, TAT2 accumulated in the plasma
membrane and the vacuolar membrane. The TAT2 pro-
tein behaved similarly in the doa4/npi2 mutant as in the
npi1/rsp5 mutant (data not shown). The accumulation of
TAT2 in the vacuolar membrane of the doa4/npi2 and
npi1/rsp5 mutants is possibly due to a constitutive vacuolar
protease defect in these nonconditional mutants (Latter-
ich and Watson, 1991). In rapamycin-treated end4 cells
(shifted to nonpermissive temperature before drug treat-
ment), the TAT2 signal was faint and corresponded
mainly to the plasma membrane, indicating that an en-
docytosis defect protects plasma membrane TAT2 but not
internal TAT2 from rapamycin-induced degradation (note
that the exposure time for the TAT2 signal in the end4
cells in Fig. 4 was sixfold longer as compared with the ex-
posure time for the npi1 cells). The stabilization of only
the plasma membrane pool of TAT2, a small portion of
the total pool, by an endocytosis defect accounts for why
TAT2 was only weakly resistant to degradation in the
end4 mutant (see above). In rapamycin-treated pep4 cells,
TAT2 accumulated mainly in the vacuolar membrane.
The cellular distribution of TAT2 in rapamycin-untreated
doa4/npi2, npi1/rsp5, and pep4 cells was the same as de-
scribed above for these cells when rapamycin treated. This
may reflect a basal level of TAT2 turnover in exponen-
tially growing (rapamycin-untreated) cells. Because the
doa4/npi2,  npi1/rsp5, and pep4 mutations are constitutive,
a defect in basal internalization and degradation of TAT2
may result in an aberrant accumulation of the permease
even in growing cells.
To investigate further the involvement of ubiquitination
in TAT2 degradation, we examined if TAT2 itself is ubiq-
uitinated. The permease was immunoprecipitated from ra-
pamycin-treated cells expressing HA-TAT2 alone or coex-
Figure 4. Cellular distribution of HA-
TAT2 by indirect immunofluorescence.
Wild-type (wt, JK9-3d) and npi1 (27038a)
and pep4 (MH684) mutant strains trans-
formed with pHA-TAT2 (pAS55 or, in the
case of pep4, pAS64) were grown in SC
medium at 308C to early logarithmic
phase. The shown wild-type cells were not
treated with rapamycin. All other cells
shown were treated with rapamcyin for
60 min. The conditional end4 mutant
(RH1597/pAS55) was grown at 248C and
shifted to 378C for 5 min before the addi-
tion of rapamycin. Cells were fixed and
processed for detection of HA-TAT2 by
immunofluorescence (see Materials and
Methods). The cellular distribution of
HA-TAT2 is shown in the left column
(TAT2). The same field of cells is shown
in the middle (Normarski) and right col-
umns (DNA). The right column shows the
cells stained with the DNA specific stain
DAPI. The endoplasmic reticulum corre-
sponds to the area encircling the DAPI-
staining nucleus (see arrowheads in wt
cells). The vacuole appears as a large cra-
ter in cells visualized by Nomarski optics
(see arrowheads in npi1 and pep4 cells).
The exposure time to visualize HA-TAT2
in  end4 cells was approximately sixfold
longer than for other strains shown.Beck et al. TOR Controls Amino Acid Permeases 1233
pressing HA-TAT2 and myc-tagged ubiquitin (myc-Ub)
(Ellison and Hochstrasser, 1991). Probing with an anti-HA
antibody revealed the signal for TAT2 (z50 kD) in both
immunoprecipitates, whereas probing with an anti-myc
antibody revealed only .50 kD proteins solely in the im-
munoprecipitate derived from cells coexpressing myc-Ub
(Fig. 3 B). Neither signal was detected in immunoprecipi-
tates from cells expressing an untagged version of TAT2.
This suggests that TAT2 is ubiquitinated. Taken together,
the above results indicate that TAT2 degradation involves
ubiquitination, vacuolar proteases, and, in part, endo-
cytosis.
The NH2 Terminus of TAT2 Is Required for 
Ubiquitination and Degradation
Ligand-induced ubiquitination and internalization of
the pheromone receptor STE2 involves the sequence
SINDAKSS within the cytosolic tail of the receptor
(Hicke et al., 1998). Replacement of the aspartic acid to
alanine or the lysine residue to an arginine in the DAKS
core of this motif impairs the internalization of a truncated
form of the receptor, whereas mutation of the aspartic acid
to glutamic acid, or substitution of the first serine by
an alanine, did not interfere with endocytosis. According
to a structure prediction by the TOP PRED algorithm,
both the NH2-terminal and COOH-terminal sequences of
TAT2 face the cytoplasm. In the extreme NH2 terminus of
TAT2, two ExKS motifs, similar to the DxKS core of the
STE2 SINDAKSS motif, are present (Fig. 5 A, amino ac-
ids 18–21 and 27–30).
To determine whether the NH2 terminus of TAT2 is re-
quired for the degradation of the permease, we expressed
several NH2-terminal deletion variants of the permease,
and assayed their stability in rapamycin-treated cells (Fig.
5 A). Whereas deletion of up to amino acid 29 (TAT2D29)
had no effect, deletion of the NH2-terminal 31 amino acids
(TAT2D31) completely stabilized the protein (Fig. 5 A).
To further characterize the sequence required for degra-
dation, a smaller deletion that completely removed the
two ExKS motifs within the NH2-terminal 31 amino acids
was constructed (TAT2D17-31, Fig. 5 A). However, this
deletion did not result in a degradation-resistant variant of
TAT2, suggesting that the ExKS motifs are not essential
for TAT2 degradation.
Ubiquitin is attached to lysine residues in target pro-
teins. There are five lysine residues in the NH2-terminal 31
amino acids of TAT2, and the above analysis suggests that
all five lysines must be deleted to prevent TAT2 degrada-
tion. To determine if one or more of the lysines is required
for degradation, possibly as an acceptor for ubiquitin, all
five lysines were changed to arginines. Single lysine mu-
tants and several combinations, including a combination of
all five substitutions, were examined for stability upon ra-
pamycin treatment (Fig. 5 A for TAT25K.R, and data not
shown). Stabilization of TAT2 was observed only when all
five lysine residues were exchanged for arginines. Further-
more, the TAT25K.R protein was approximately threefold
more abundant (in rapamycin-treated and untreated cells)
than wild-type TAT2 in rapamycin-untreated cells (data
not shown). This increase in the level of TAT25K.R was
similar to the increase of wild-type TAT2 caused by a de-
fect in the ubiquitination machinery, as described above,
and may again reflect a loss of basal turnover of the per-
mease. Immunofluorescence on rapamycin-treated and
-untreated cells revealed a pronounced accumulation of
TAT25K.R in the plasma membrane, with no detectable
signal elsewhere in the cell (Fig. 5 B, and data not shown).
As observed for wild-type TAT2 in ubiquitination mu-
tants, the similar pattern for rapamycin-treated and -un-
treated cells may reflect an aberrantly high accumulation
of the stabilized permease in the plasma membrane even
in growing cells. The TAT2D29K31R and TAT2D31 pro-
teins behaved identically to TAT25K.R with regard to
both abundance and localization (data not shown). Fi-
nally, probing immunoprecipitated TAT25K.R for ubiq-
uitin failed to reveal any ubiquitinated forms of TAT25K.R
(Fig. 3 B). Taken together, these results suggest that at
least one lysine residue within the NH2-terminal 31 amino
Figure 5. The NH2 terminus of TAT2 is required for degrada-
tion. (A) Cells expressing HA-TAT2 containing NH2-terminal
mutations were grown to early logarithmic phase in SC medium
(JK9-3d containing either pHA-TAT2D10, pHA-TAT2D17,
pHA-TAT2D20, pHA-TAT2D29, pHA-TAT2D29K31R, pHA-
TAT2D31, pHA-TAT2D17-31, or pHA-TAT25K.R). Rapamycin
was added to one half of each culture. After 60 min of further in-
cubation, extracts were prepared and assayed for HA-TAT2 by
Western analysis. The levels of the mutant forms of HA-TAT2
are not normalized to the levels of wild-type HA-TAT2 (due to
different exposure times), and thus an increased abundance for
the stabilized proteins, as described in the text, is not reflected in
these data. The numbering of amino acids refers to untagged
TAT2. (B) TAT25K.R accumulates in the plasma membrane.
Wild-type cells (JK9-3d) expressing HA-TAT25K.R were grown
in SC medium to early logarithmic phase, treated with rapamycin
for 60 min, and processed for visualization of HA-TAT25K.R by
immunofluorescence (see Fig. 4 legend).The Journal of Cell Biology, Volume 146, 1999 1234
acids of TAT2 is necessary for ubiquitination and degrada-
tion of at least the plasma membrane pool of the per-
mease.
Upon Starvation, TAT2 Is Sorted from Internal 
Compartments to the Vacuole Independently of the 
Plasma Membrane
If internal TAT2 is transported to the vacuole via the
plasma membrane, TAT2 should be completely stabilized
in an end4 mutant, due to a block in plasma membrane in-
ternalization. However, results presented above indicate
that the large intracellular pool of TAT2 is degraded in an
end4 mutant, suggesting that internal TAT2 is sorted to
the vacuole independently of the plasma membrane. To
investigate if TAT2 is targeted from the ER and the Golgi
to the vacuole without passing through the plasma mem-
brane, we examined the stability of TAT2 in sec4, sec18,
and sec23 mutants. SEC4 (Goud et al., 1988) is a small
GTPase required for fusion of Golgi-derived vesicles with
the plasma membrane. SEC23 (Hicke and Schekman,
1989) is a subunit of the COPII complex required for ER
to Golgi transport. SEC18 (Eakle et al., 1988) is the yeast
NSF homologue and is generally required for fusion of
vesicles with acceptor membranes (reviewed in Kaiser et
al., 1997). The amounts of TAT2 in extracts of rapamycin-
treated wild-type cells and the sec mutants were compared
by Western analysis (Fig. 6). In the sec4 mutant, TAT2 was
degraded like in wild-type cells. In contrast, TAT2 was
completely stable in the sec18 mutant and mostly stable in
the sec23 mutant. Taken together, the above results sug-
gest that TAT2 is targeted from the ER and the Golgi to
the vacuole independently of the plasma membrane. Thus,
upon starvation, TAT2 appears to be diverted from the
secretory pathway to the vacuolar pathway.
Recently, TOR has been implicated in the control of au-
tophagy, a starvation-induced process in which bulk cyto-
plasm, including organelles, is membrane enclosed and
transported to the vacuole (Noda and Ohsumi, 1998).
Since the effect of rapamycin on TAT2 is a starvation re-
sponse, and rapamycin exerts its effects by inhibiting the
TOR proteins, we asked whether the degradation of
TAT2 is an autophagic event. TAT2 stability was exam-
ined in an apg1 mutant defective for autophagy (Matsuura
et al., 1997). In the presence of rapamycin, HA-TAT2 was
completely turned over in the apg1 strain, indicating that
autophagy is not required for the degradation of TAT2 in
response to starvation (Fig. 6).
Because starvation-induced degradation of intracellular
TAT2 does not rely on passage through the cell surface or
on autophagy, a likely transport route to the vacuole is
via the PEP12-, VPS45-, and VPS27-dependent pathway
(Cowles et al., 1994; Piper et al., 1994, 1995; Becherer et al.,
1996). In this VPS pathway, proteins are delivered from
the Golgi to the vacuole via a prevacuolar/endosomal
compartment. If TAT2 is transported to the vacuole via
the VPS pathway, the permease should be stable in a rapa-
mycin-treated mutant defective in this pathway. Indeed,
TAT2 was still present in extracts of rapamycin-treated
pep12, vps27, and vps45 cells (Fig. 6, data not shown).
Taken together, the above results suggest that upon nutri-
ent depletion, TAT2 is transported from the ER and Golgi
to the vacuole via the VPS pathway, without passing
through the cell surface.
Mutation of the five NH2-terminal lysine residues in
TAT2 results in an apparently complete stabilization of
the permease (see Fig. 5 A), suggesting that the intracellu-
lar pool of TAT2, in addition to the plasma membrane
pool (see above), requires ubiquitination for rapamycin-
induced targeting to the vacuole and degradation. To in-
vestigate whether the NH2-terminal lysine residues are
required for degradation of the internal pool of TAT2,
temperature-sensitive sec4 cells expressing either HA-
TAT2 or HA-TAT25K.R were pulse labeled for 3 min at
permissive temperature, shifted to nonpermissive tempera-
ture, and chased in the presence of rapamycin (see Materi-
als and Methods). This experiment was designed to investi-
gate the fate of newly made intracellular TAT2 and
TAT25K.R proteins that are unable to reach the plasma
membrane due to the sec4 mutation. Whereas newly made
HA-TAT2 was rapidly degraded in rapamycin-treated
cells, HA-TAT25K.R was stable over a 90-min chase period
(Fig. 7), suggesting that the NH2-terminal lysine residues of
TAT2 and ubiquitination are also required for rapamycin-
induced degradation of the internal pool of TAT2.
Discussion
We have shown that the tryptophan permease TAT2, a
constitutive amino acid permease, is indeed regulated, at
Figure 6. Upon starvation, TAT2 is sorted from internal com-
partments to the vacuole  independently of the plasma mem-
brane. A parental wild-type strain (RSY255), and sec4 (RH1552),
sec18  (RSY271),  sec23 (RSY281), apg1 (MT16-9B), pep12
(CBY9/5C), and vps27 (RH2379) mutants expressing HA-TAT2
(pAS55) were grown at 248C to early logarithmic phase and
shifted to 378C for 5 min (10 min for the pep12 mutant). Rapa-
mycin was added to half of each culture. After 60 min of further
incubation, cells were harvested and processed for Western anal-
ysis.
Figure 7. NH2-terminal
lysine residues of TAT2 are
required for rapamycin-
induced degradation of
newly  made TAT2. Temper-
ature-sensitive sec4 mutant cells expressing HA-TAT2 (pAS55)
or HA-TAT25K.R (pTB355) were grown in SC medium at 248C
to early logarithmic phase, labeled with 35S-methionine for 3 min
and shifted to 378C for 5 min. Labeled cells were harvested and
chased at 378C in SC medium containing 200 ng/ml of rapamycin.
Aliquots were taken at the indicated times of chase, and cell ex-
tracts were prepared. HA-TAT2 or HA-TAT25K.R was immuno-
precipitated, eluted from the washed protein G–Sepharose beads
at 378C, subjected to SDS-PAGE, and visualized by fluorography
(for details, see Materials and Methods).Beck et al. TOR Controls Amino Acid Permeases 1235
the level of protein sorting and stability. In starved cells,
rapamycin-treated or nutrient-deprived, TAT2 is ubiquiti-
nated, targeted from the plasma membrane, the ER, and
the Golgi to the vacuole, and then degraded. The internal
TAT2 is routed to the vacuole independently of the
plasma membrane. The regulation of the specific amino
acid permease TAT2 is inverse to that of the broad-range
permease GAP1. GAP1 is routed to the vacuole and de-
graded in nonstarved cells (Roberg et al., 1997a; Springael
and Andre, 1998). Rapamycin inhibits the TOR proteins,
and induces both the downregulation of TAT2 and the up-
regulation of GAP1. Thus, TOR and presumably the TOR
nutrient-signaling pathway mediate the inversely regu-
lated sorting and stability of the two types of permeases. A
model summarizing our findings is shown in Fig. 8.
In growing cells, TAT2 follows the secretory pathway to
the plasma membrane. In starved cells, TAT2 is targeted
to the vacuole. How is this regulated sorting of TAT2 con-
trolled? Ubiquitination is important in targeting TAT2
from the plasma membrane to the vacuole, as TAT2 accu-
mulates in the plasma membrane in ubiquitination mu-
tants. Furthermore, mutant TAT2 (TAT25K.R) altered in
five NH2-terminal lysine residues required for ubiquitina-
tion accumulates in the plasma membrane in wild-type
cells. Ubiquitination may also be required for diverting in-
tracellular TAT2 to the vacuole, as newly made intracellu-
lar TAT25K.R is not degraded upon rapamycin treatment
(Fig. 7). Jenness et al. (1997) have suggested that ubiquiti-
nation is required for delivery of a mutant STE2 phero-
mone receptor from an intracellular site to the vacuole.
The mechanism by which ubiquitination may divert the in-
ternal pool of TAT2 from the secretory pathway to the
vacuolar pathway upon nutrient deprivation remains to be
determined. The alternative routing of GAP1 to the cell
surface or the vacuole appears to be controlled at the level
of GAP1 packaging into specialized vesicles leaving the
Golgi (Roberg et al., 1997b).
TAT2, and at least the histidine permease HIP1, are
turned over upon starvation. This is a novel aspect of the
starvation response in yeast cells. Why are specific per-
meases turned over upon starvation? The specific per-
mease TAT2 and the broad-range permease GAP1 are
regulated inversely, at least in response to the quality and
quantity of the nitrogen source. There are several specific
permeases but only two known broad-range permeases,
GAP1 and AGP1, in yeast (Grenson et al., 1970; Jauniaux
and Grenson, 1990; Nelissen et al., 1997; Schreve et al.,
1998). We suggest that specific amino acid permeases are
expressed and functionally maintained under nutrient-rich
conditions, and are probably fine-regulated by the avail-
ability of their substrates. Once nutrients become limiting,
cells may express and maintain only a couple broad-range
permeases, instead of the several specific permeases, as a
means to reduce energy consumption. The inverse regula-
tion of specific and broad-range permeases provides a
mechanism to optimize import with regard to the quality
and quantity of nutrients.
Upon rapamycin treatment or upon shift from a good
nitrogen source (ammonium) to a poor nitrogen source
(proline), GAP1 is stabilized and TAT2 is degraded. How
is this inverse regulation of TAT2 and GAP1 achieved?
To date, two posttranslational regulators of GAP1 are
known, NPI1 and NPR1. NPI1, a ubiquitin ligase, presum-
ably ubiquitinates GAP1 and thereby triggers the internal-
ization and degradation of the permease (Springael and
Andre, 1998). NPR1, a Ser/Thr protein kinase, is a positive
regulator of GAP1 (Vandenbol et al., 1987). The mecha-
nism by which NPR1 activates GAP1 is unknown, but the
finding that GAP1 is phosphorylated when active suggests
that NPR1 directly phosphorylates GAP1 and thereby
protects it from NPI1-dependent degradation (Stanbrough
and Magasanik, 1995). NPI1 is also responsible for inacti-
vation of TAT2. Thus, we consider an inverse regulation
via this ubiquitin ligase unlikely. However, the inverse reg-
ulation may be achieved through NPR1. Indeed, we have
found that NPR1 mediates the destruction of TAT2 under
conditions when the kinase protects GAP1 (Schmidt et al.,
1998). Furthermore, we have shown that NPR1 is con-
trolled by TOR and the TOR downstream effector TAP42
(Schmidt et al., 1998). Because TAT2 is regulated in re-
sponse to nitrogen, carbon and amino acid availability, it is
of interest to determine whether GAP1 is also regulated in
response to nutrients other than nitrogen. Furthermore, it
remains to be determined how the TOR nutrient–signal-
ing pathway senses the availability of nutrients.
We thank Howard Riezman and Rosine Haguenauer-Tsapis for strains,
plasmids, and helpful discussion, and Bruno André, Mark Hochstrasser,
Per Ljungdahl, and Greg Payne for strains and plasmids.
Figure 8. Model for inverse regulation of specific (TAT2) and
broad-range (GAP1) amino acid permeases by TOR in response
to nutrients. (A) In the presence of nutrients, active TOR medi-
ates the sorting of TAT2 to the plasma membrane and the rout-
ing of GAP1 to the vacuole for degradation. (B) Upon nutrient
deprivation, TOR is inactive and TAT2 is targeted to the vacuole
for degradation whereas GAP1 is routed to the plasma mem-
brane. TOR is associated with the plasma membrane.The Journal of Cell Biology, Volume 146, 1999 1236
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